Quantcast

Latest Mission Pharmacal Company Stories

2014-05-29 20:22:54

New offering through an agreement with Meda AB expands Mission's women's healthcare options SAN ANTONIO, May 29, 2014 /PRNewswire/ -- Mission Pharmacal Company has begun exclusive promotion of Elestrin® (estradiol gel) 0.06% in the United States through an agreement with Meda AB. Elestrin is a prescription medicine approved by the Food and Drug Administration (FDA) for use as a topical hormone replacement gel to treat moderate-to-severe hot flashes due to menopause. Using estrogen-alone may...

2014-04-23 12:31:12

National initiative raises funds for March of Dimes® efforts to help moms have full-term pregnancies and healthy babies. SAN ANTONIO, April 23, 2014 /PRNewswire/ -- Mission Pharmacal Company continues for the fifth consecutive year as a national sponsor of March for Babies®, the March of Dimes® premier fundraising event. The March of Dimes is a leading nonprofit organization committed to helping moms have full-term pregnancies and healthy babies. This year's March for Babies event...

2014-03-27 12:30:45

New patented formulation provides essential nutrients with added comfort for women. SAN ANTONIO, Texas, March 27, 2014 /PRNewswire/ -- Mission Pharmacal Company today announced the availability of a new, patented dual-iron version of its premier prenatal vitamin, CitraNatal Harmony, the first and only single-pill prescription supplement with calcium citrate. The new, improved product features Ferr-Ease®, a patented blend of ferrous fumarate, a rapidly absorbing iron salt, and...

2014-03-20 16:27:05

New products from Mission ideal for nursing home environment. SAN ANTONIO, March 20, 2014 /PRNewswire/ -- Mission Pharmacal Company is introducing a portfolio of proven products into the long-term care environment. The company has always held steadfast to its dedication to provide the highest quality healthcare medications and treatments for a wide range of conditions and diseases. http://photos.prnewswire.com/prnvar/20140320/PH87885LOGO The long-term care (LTC) initiative capitalizes on...

2014-01-15 16:23:21

BINOSTO® offers a liquid alternative to the 74 percent of patients who want a treatment choice. SAN ANTONIO, Jan. 15, 2014 /PRNewswire/ -- Most osteoporosis patients want a choice in the medication they take, according to a recent online survey* sponsored by Mission Pharmacal Company. The survey, conducted by Inspire among the National Osteoporosis Foundation online support community, revealed that 74 percent of osteoporosis patients surveyed prefer to take medication that comes in...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.